Tomotaka Ugai

Tomotaka Ugai

researcher Japan

Dr. Tomotaka Ugai is a prominent researcher in the field of gastrointestinal health, known for his work on the relationship between diet, gut microbiome, and colorectal cancer. As a co-author of a recent study published in Gut Microbes, he highlighted the potential protective effects of yogurt consumption against Bifidobacterium-positive colorectal tumors. His research contributes significantly to understanding how dietary habits can influence cancer risk and overall health.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
81,867
Power
3,942$
Sentiment
7.27
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United States 1 7.00 0.02% +0% 331,002,651 59,501 $21,000,000 3,775$
Colombia 1 9.00 0.04% +0% 50,882,884 21,052 $350,000 145$
Croatia 1 8.00 0.03% +0% 4,105,267 1,314 $68,000 22$
Totals 3 385,990,802 81,867 $21,418,000 3,942$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Colombia Colombia: Tomotaka Ugai is from the Department of Pathology at Brigham and the Department of Epidemiology at the Harvard TH Chan School of Public Health. 9

El Tiempo: Doctor de Harvard revela el alimento que debe consumir para prevenir el cáncer de colon

United States United States: Dr. Tomotaka Ugai, one of the study's co-senior authors, told Fox News Digital he was not surprised by the results. 7

Fox News: Yogurt has unexpected benefit: cancer prevention

Croatia Croatia: Co-author Dr. Tomotaka Ugai highlighted that this research provides evidence of yogurt's protective effects specific to Bifidobacterium-positive tumors. 8

Jutarnji List – Croatian daily newspaper, est. 1998: Dugotrajna konzumacija jogurta može smanjiti učestalost kolorektalnog raka, sugerira nova studija